Spatial Assay Distiller: 18,000-Gene Discovery to 60-Marker Clinical Panel

A fee-for-service program that takes a sponsor's ultra-high-plex spatial tumor maps (platforms reading ~18,000 genes in tissue) and distills them into a compact, standardized protein panel plus an explainable AI scoring model that runs on clinically deployable spatial platforms — turning a research discovery into a real diagnostic assay.